▶ 調査レポート

世界の植物性薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Plant Derivative Drug Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の植物性薬市場規模・現状・予測(2021年-2027年) / Global Plant Derivative Drug Market Size, Status and Forecast 2021-2027 / QFJ1-5952資料のイメージです。• レポートコード:QFJ1-5952
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、植物性薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(処方薬、OTC)、用途別市場規模(循環器、腫瘍、呼吸器系、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・植物性薬の市場動向
・企業の競争状況、市場シェア
・植物性薬の種類別市場規模と予測2016-2027(処方薬、OTC)
・植物性薬の用途別市場規模と予測2016-2027(循環器、腫瘍、呼吸器系、その他)
・植物性薬の北米市場規模2016-2027(アメリカ、カナダ)
・植物性薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・植物性薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・植物性薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・植物性薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Buchang Pharmaceuticals、China TCM、Tsumura、Schwabe、Tong Ren Tang、Jumpcan Pharmaceutical、Guangzhou Baiyunshan Pharmaceutical、Yunnan Baiyao、Tasly Holding Group、Bionorica Se、Huarun 999、Taiji、Weleda、Kwangdong、GW Pharmaceuticals)
・結論

A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.

Market Analysis and Insights: Global Plant Derivative Drug Market
The global Plant Derivative Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plant Derivative Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plant Derivative Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plant Derivative Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plant Derivative Drug market.

Global Plant Derivative Drug Scope and Market Size
Plant Derivative Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plant Derivative Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Prescription Drug
OTC

Segment by Application
Cardiovascular
Tumor
Respiratory System
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plant Derivative Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Plant Derivative Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Plant Derivative Drug Market Perspective (2016-2027)
2.2 Plant Derivative Drug Growth Trends by Regions
2.2.1 Plant Derivative Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plant Derivative Drug Historic Market Share by Regions (2016-2021)
2.2.3 Plant Derivative Drug Forecasted Market Size by Regions (2022-2027)
2.3 Plant Derivative Drug Industry Dynamic
2.3.1 Plant Derivative Drug Market Trends
2.3.2 Plant Derivative Drug Market Drivers
2.3.3 Plant Derivative Drug Market Challenges
2.3.4 Plant Derivative Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Plant Derivative Drug Players by Revenue
3.1.1 Global Top Plant Derivative Drug Players by Revenue (2016-2021)
3.1.2 Global Plant Derivative Drug Revenue Market Share by Players (2016-2021)
3.2 Global Plant Derivative Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plant Derivative Drug Revenue
3.4 Global Plant Derivative Drug Market Concentration Ratio
3.4.1 Global Plant Derivative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plant Derivative Drug Revenue in 2020
3.5 Plant Derivative Drug Key Players Head office and Area Served
3.6 Key Players Plant Derivative Drug Product Solution and Service
3.7 Date of Enter into Plant Derivative Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Plant Derivative Drug Breakdown Data by Type
4.1 Global Plant Derivative Drug Historic Market Size by Type (2016-2021)
4.2 Global Plant Derivative Drug Forecasted Market Size by Type (2022-2027)

5 Plant Derivative Drug Breakdown Data by Application
5.1 Global Plant Derivative Drug Historic Market Size by Application (2016-2021)
5.2 Global Plant Derivative Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Plant Derivative Drug Market Size (2016-2027)
6.2 North America Plant Derivative Drug Market Size by Type
6.2.1 North America Plant Derivative Drug Market Size by Type (2016-2021)
6.2.2 North America Plant Derivative Drug Market Size by Type (2022-2027)
6.2.3 North America Plant Derivative Drug Market Size by Type (2016-2027)
6.3 North America Plant Derivative Drug Market Size by Application
6.3.1 North America Plant Derivative Drug Market Size by Application (2016-2021)
6.3.2 North America Plant Derivative Drug Market Size by Application (2022-2027)
6.3.3 North America Plant Derivative Drug Market Size by Application (2016-2027)
6.4 North America Plant Derivative Drug Market Size by Country
6.4.1 North America Plant Derivative Drug Market Size by Country (2016-2021)
6.4.2 North America Plant Derivative Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Plant Derivative Drug Market Size (2016-2027)
7.2 Europe Plant Derivative Drug Market Size by Type
7.2.1 Europe Plant Derivative Drug Market Size by Type (2016-2021)
7.2.2 Europe Plant Derivative Drug Market Size by Type (2022-2027)
7.2.3 Europe Plant Derivative Drug Market Size by Type (2016-2027)
7.3 Europe Plant Derivative Drug Market Size by Application
7.3.1 Europe Plant Derivative Drug Market Size by Application (2016-2021)
7.3.2 Europe Plant Derivative Drug Market Size by Application (2022-2027)
7.3.3 Europe Plant Derivative Drug Market Size by Application (2016-2027)
7.4 Europe Plant Derivative Drug Market Size by Country
7.4.1 Europe Plant Derivative Drug Market Size by Country (2016-2021)
7.4.2 Europe Plant Derivative Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Plant Derivative Drug Market Size (2016-2027)
8.2 Asia-Pacific Plant Derivative Drug Market Size by Type
8.2.1 Asia-Pacific Plant Derivative Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plant Derivative Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plant Derivative Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Plant Derivative Drug Market Size by Application
8.3.1 Asia-Pacific Plant Derivative Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plant Derivative Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plant Derivative Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Plant Derivative Drug Market Size by Region
8.4.1 Asia-Pacific Plant Derivative Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plant Derivative Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Plant Derivative Drug Market Size (2016-2027)
9.2 Latin America Plant Derivative Drug Market Size by Type
9.2.1 Latin America Plant Derivative Drug Market Size by Type (2016-2021)
9.2.2 Latin America Plant Derivative Drug Market Size by Type (2022-2027)
9.2.3 Latin America Plant Derivative Drug Market Size by Type (2016-2027)
9.3 Latin America Plant Derivative Drug Market Size by Application
9.3.1 Latin America Plant Derivative Drug Market Size by Application (2016-2021)
9.3.2 Latin America Plant Derivative Drug Market Size by Application (2022-2027)
9.3.3 Latin America Plant Derivative Drug Market Size by Application (2016-2027)
9.4 Latin America Plant Derivative Drug Market Size by Country
9.4.1 Latin America Plant Derivative Drug Market Size by Country (2016-2021)
9.4.2 Latin America Plant Derivative Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Plant Derivative Drug Market Size (2016-2027)
10.2 Middle East & Africa Plant Derivative Drug Market Size by Type
10.2.1 Middle East & Africa Plant Derivative Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plant Derivative Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plant Derivative Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Plant Derivative Drug Market Size by Application
10.3.1 Middle East & Africa Plant Derivative Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plant Derivative Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plant Derivative Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Plant Derivative Drug Market Size by Country
10.4.1 Middle East & Africa Plant Derivative Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plant Derivative Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Details
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Plant Derivative Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2016-2021)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Details
11.2.2 China TCM Business Overview
11.2.3 China TCM Plant Derivative Drug Introduction
11.2.4 China TCM Revenue in Plant Derivative Drug Business (2016-2021)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Details
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Plant Derivative Drug Introduction
11.3.4 Tsumura Revenue in Plant Derivative Drug Business (2016-2021)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Details
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Plant Derivative Drug Introduction
11.4.4 Schwabe Revenue in Plant Derivative Drug Business (2016-2021)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Details
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Plant Derivative Drug Introduction
11.5.4 Tong Ren Tang Revenue in Plant Derivative Drug Business (2016-2021)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Details
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Plant Derivative Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2016-2021)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2016-2021)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Details
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Plant Derivative Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Plant Derivative Drug Business (2016-2021)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Details
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Plant Derivative Drug Introduction
11.9.4 Tasly Holding Group Revenue in Plant Derivative Drug Business (2016-2021)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Details
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Plant Derivative Drug Introduction
11.10.4 Bionorica Se Revenue in Plant Derivative Drug Business (2016-2021)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Details
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Plant Derivative Drug Introduction
11.11.4 Huarun 999 Revenue in Plant Derivative Drug Business (2016-2021)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Details
11.12.2 Taiji Business Overview
11.12.3 Taiji Plant Derivative Drug Introduction
11.12.4 Taiji Revenue in Plant Derivative Drug Business (2016-2021)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Details
11.13.2 Weleda Business Overview
11.13.3 Weleda Plant Derivative Drug Introduction
11.13.4 Weleda Revenue in Plant Derivative Drug Business (2016-2021)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Details
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Plant Derivative Drug Introduction
11.14.4 Kwangdong Revenue in Plant Derivative Drug Business (2016-2021)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Details
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Plant Derivative Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2016-2021)
11.15.5 GW Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Plant Derivative Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Plant Derivative Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Plant Derivative Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Plant Derivative Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Plant Derivative Drug Market Share by Regions (2016-2021)
Table 8. Global Plant Derivative Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Plant Derivative Drug Market Share by Regions (2022-2027)
Table 10. Plant Derivative Drug Market Trends
Table 11. Plant Derivative Drug Market Drivers
Table 12. Plant Derivative Drug Market Challenges
Table 13. Plant Derivative Drug Market Restraints
Table 14. Global Plant Derivative Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Plant Derivative Drug Market Share by Players (2016-2021)
Table 16. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plant Derivative Drug as of 2020)
Table 17. Ranking of Global Top Plant Derivative Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Plant Derivative Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plant Derivative Drug Product Solution and Service
Table 21. Date of Enter into Plant Derivative Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Plant Derivative Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Plant Derivative Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Plant Derivative Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Plant Derivative Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Plant Derivative Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Plant Derivative Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Plant Derivative Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Plant Derivative Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Plant Derivative Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Buchang Pharmaceuticals Company Details
Table 62. Buchang Pharmaceuticals Business Overview
Table 63. Buchang Pharmaceuticals Plant Derivative Drug Product
Table 64. Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 65. Buchang Pharmaceuticals Recent Development
Table 66. China TCM Company Details
Table 67. China TCM Business Overview
Table 68. China TCM Plant Derivative Drug Product
Table 69. China TCM Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 70. China TCM Recent Development
Table 71. Tsumura Company Details
Table 72. Tsumura Business Overview
Table 73. Tsumura Plant Derivative Drug Product
Table 74. Tsumura Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 75. Tsumura Recent Development
Table 76. Schwabe Company Details
Table 77. Schwabe Business Overview
Table 78. Schwabe Plant Derivative Drug Product
Table 79. Schwabe Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 80. Schwabe Recent Development
Table 81. Tong Ren Tang Company Details
Table 82. Tong Ren Tang Business Overview
Table 83. Tong Ren Tang Plant Derivative Drug Product
Table 84. Tong Ren Tang Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 85. Tong Ren Tang Recent Development
Table 86. Jumpcan Pharmaceutical Company Details
Table 87. Jumpcan Pharmaceutical Business Overview
Table 88. Jumpcan Pharmaceutical Plant Derivative Drug Product
Table 89. Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 90. Jumpcan Pharmaceutical Recent Development
Table 91. Guangzhou Baiyunshan Pharmaceutical Company Details
Table 92. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 93. Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product
Table 94. Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 95. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 96. Yunnan Baiyao Company Details
Table 97. Yunnan Baiyao Business Overview
Table 98. Yunnan Baiyao Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 99. Yunnan Baiyao Recent Development
Table 100. Tasly Holding Group Company Details
Table 101. Tasly Holding Group Business Overview
Table 102. Tasly Holding Group Plant Derivative Drug Product
Table 103. Tasly Holding Group Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 104. Tasly Holding Group Recent Development
Table 105. Bionorica Se Company Details
Table 106. Bionorica Se Business Overview
Table 107. Bionorica Se Plant Derivative Drug Product
Table 108. Bionorica Se Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 109. Bionorica Se Recent Development
Table 110. Huarun 999 Company Details
Table 111. Huarun 999 Business Overview
Table 112. Huarun 999 Plant Derivative Drug Product
Table 113. Huarun 999 Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 114. Huarun 999 Recent Development
Table 115. Taiji Company Details
Table 116. Taiji Business Overview
Table 117. Taiji Plant Derivative Drug Product
Table 118. Taiji Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 119. Taiji Recent Development
Table 120. Weleda Company Details
Table 121. Weleda Business Overview
Table 122. Weleda Plant Derivative Drug Product
Table 123. Weleda Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 124. Weleda Recent Development
Table 125. Kwangdong Company Details
Table 126. Kwangdong Business Overview
Table 127. Kwangdong Plant Derivative Drug Product
Table 128. Kwangdong Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 129. Kwangdong Recent Development
Table 130. GW Pharmaceuticals Company Details
Table 131. GW Pharmaceuticals Business Overview
Table 132. GW Pharmaceuticals Plant Derivative Drug Product
Table 133. GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 134. GW Pharmaceuticals Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plant Derivative Drug Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drug Features
Figure 3. OTC Features
Figure 4. Global Plant Derivative Drug Market Share by Application: 2020 VS 2027
Figure 5. Cardiovascular Case Studies
Figure 6. Tumor Case Studies
Figure 7. Respiratory System Case Studies
Figure 8. Other Case Studies
Figure 9. Plant Derivative Drug Report Years Considered
Figure 10. Global Plant Derivative Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Plant Derivative Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Plant Derivative Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Plant Derivative Drug Market Share by Regions (2022-2027)
Figure 14. Global Plant Derivative Drug Market Share by Players in 2020
Figure 15. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plant Derivative Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Plant Derivative Drug Revenue in 2020
Figure 17. Global Plant Derivative Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Plant Derivative Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Plant Derivative Drug Market Share by Type (2016-2027)
Figure 21. North America Plant Derivative Drug Market Share by Application (2016-2027)
Figure 22. North America Plant Derivative Drug Market Share by Country (2016-2027)
Figure 23. United States Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Plant Derivative Drug Market Share by Type (2016-2027)
Figure 27. Europe Plant Derivative Drug Market Share by Application (2016-2027)
Figure 28. Europe Plant Derivative Drug Market Share by Country (2016-2027)
Figure 29. Germany Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Plant Derivative Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Plant Derivative Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Plant Derivative Drug Market Share by Region (2016-2027)
Figure 39. China Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Plant Derivative Drug Market Share by Type (2016-2027)
Figure 47. Latin America Plant Derivative Drug Market Share by Application (2016-2027)
Figure 48. Latin America Plant Derivative Drug Market Share by Country (2016-2027)
Figure 49. Mexico Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Plant Derivative Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Plant Derivative Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Plant Derivative Drug Market Share by Country (2016-2027)
Figure 55. Turkey Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Buchang Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 59. China TCM Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 60. Tsumura Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 61. Schwabe Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 62. Tong Ren Tang Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 63. Jumpcan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 64. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 65. Yunnan Baiyao Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 66. Tasly Holding Group Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 67. Bionorica Se Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 68. Huarun 999 Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 69. Taiji Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 70. Weleda Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 71. Kwangdong Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 72. GW Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed